At WTO, Governments, Health Advocates See Benefit From TRIPS; LDC Waiver Urged

Access to medicines and innovations was the subject of a panel organised at the World Trade Organization Public Forum last week. After 20 years of the WTO intellectual property agreement, panellists looked at the impact of the agreement on access to medicines, and in particular the use of its flexibilities. In addition, a delegate of India detailed the legal-political aspects of an upcoming WTO decision on disputes for harmful actions that do not technically violate any WTO rules.








